Molecular Diagnostics‐Guided Immunosuppression Minimization to Belatacept Monotherapy in Kidney Transplant Recipients
Clinical Transplantation · 2026-11 · 40 (11)
DOI: 10.1111/ctr.70772 ↗At a glance
Journal article in Clinical Transplantation, published online on 2026-11-21. Written by Juan D. Salcedo‐Betancourt and 7 co-authors. 25 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: CareDx.
Abstract (original language)
Introduction
Minimally invasive molecular diagnostics, including donor‐derived cell‐free DNA (dd‐cfDNA) and gene expression profiling, reliably distinguish immune quiescence from allograft injury; however, their utility in guiding immunosuppression minimization has not been fully evaluated.
Methods
We conducted a 12‐month prospective, single‐arm observational proof of concept study to determine whether integration of dd‐cfDNA (AlloSure), gene expression profiling (AlloMap), and conventional clinical biomarkers could facilitate immunosuppression reduction toward belatacept monotherapy in kidney transplant recipients. Adult recipients ≥9 months post‐transplant receiving belatacept‐based immunosuppression with stable renal function (eGFR >40 mL/min/1.73 m 2 ), AlloSure ≤1%, and no donor‐specific antibodies were enrolled. A three‐month lead‐in period confirmed immune quiescence prior to stepwise immunosuppression reduction.
Results
Of 25 consented participants, 23 completed the lead‐in period. Median dd‐cfDNA remained
Funding
- CareDx
Cite
APA
Salcedo‐Betancourt, J. D., Feizpour, C., Marsh, M., Han, H. S., Lakhani, L., Levea, S., Anderson, L., & Wojciechowski, D. (2026). Molecular Diagnostics‐Guided Immunosuppression Minimization to Belatacept Monotherapy in Kidney Transplant Recipients. Clinical Transplantation, 40(11). https://doi.org/10.1111/ctr.70772
Vancouver
Salcedo‐Betancourt JD, Feizpour C, Marsh M, Han HS, Lakhani L, Levea S, et al. Molecular Diagnostics‐Guided Immunosuppression Minimization to Belatacept Monotherapy in Kidney Transplant Recipients. Clinical Transplantation. 2026;40(11). doi:10.1111/ctr.70772
BibTeX
@article{SalcedoBetancourt2026,
author = {Salcedo‐Betancourt, Juan D. and Feizpour, Cyrus and Marsh, Morgan and Han, Hwarang S. and Lakhani, Laila and Levea, Swee‐Ling and Anderson, Lee and Wojciechowski, David},
title = {Molecular Diagnostics‐Guided Immunosuppression Minimization to Belatacept Monotherapy in Kidney Transplant Recipients},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {11},
doi = {10.1111/ctr.70772}
}
EUVIMED